1986
DOI: 10.1002/mpo.2950140304
|View full text |Cite
|
Sign up to set email alerts
|

The problem of “staging” in childhood acute lymphoblastic leukemia: A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

1995
1995
2010
2010

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…The quantitative nature of these variables necessitates the use of cutpoints to define prognostic subgroups and to select a treatment (Mastrangelo, 1986a;Bleyer, 1989). Sometimes a single cutpoint is chosen, but in other studies several cutpoints are selected, usually in an arbitrary manner.…”
mentioning
confidence: 99%
“…The quantitative nature of these variables necessitates the use of cutpoints to define prognostic subgroups and to select a treatment (Mastrangelo, 1986a;Bleyer, 1989). Sometimes a single cutpoint is chosen, but in other studies several cutpoints are selected, usually in an arbitrary manner.…”
mentioning
confidence: 99%
“…Interstudy variability in staging systems appears to be a major factor in the differences observed among reported outcomes. Common staging criteria would allow comparison of the results of therapeutic trials [ 5 ] , and would open the way for a new orientation in the treatment of the disease. In fact, considering the high cure rate presently obtained in ALL, only the use of common criteria among different study groups and a large number of patients to be evaluated would perhaps allow the identification of a more effective drug combination, which would not necessarily be more intensive.…”
mentioning
confidence: 99%